Translate this page into:
Total hip arthroplasty after pelvic osteotomy for acetabular dysplasia: A systematic review
∗Corresponding author: Benjamin G. Domb. DrDomb@americanhipinstitute.org
-
Received: ,
Accepted: ,
This article was originally published by Reed Elsevier India Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Abstract
The purposes were (1) to investigate and compare the findings of patients undergoing total hip arthroplasty (THA) following a corrective pelvic osteotomy (PO), to a control group of patients who underwent THA but not PO and (2) to evaluate the outcomes and complications for secondary THA after PO. Three studies recorded reduced cup anteversion in the osteotomy group. Two studies reported higher PROs for the control group. The most common complication after failed PAO was dislocations. PO may entail challenges on a subsequent THA, illustrated by higher intraoperative blood loss, lower consistency in cup positioning and compromised patients reported outcomes.
Keywords
Total hip arthroplasty
Pelvic osteotomy
Acetabular dysplasia
Systematic review
1 Introduction
Acetabular dysplasia is manifested as a structural instability of the hip and is one of the common etiologies of secondary osteoarthritis.1,2 In order to restore the stability of the hip joint, a correction of the acetabular architecture is normally achieved via pelvic osteotomy (PO).3–6 The goals of surgical management are to alleviate pain, maintain function, and ultimately to avoid osteoarthritis of the hip.2,7,8 Several reconstructive pelvic osteotomies have been developed to treat dysplastic patients with a closed triradiate cartilage, however in recent years the Bernese PO has become the PO of choice due to its favorable corrective potential.2,9,10 Regarding the outcomes, PAO has been shown not only to correlate with long-term satisfaction, but also to alter the natural history with regard to osteoarthritis progression in dysplastic patients.9 In addition to the long-term longevity of the native hip associated with PAO, other reconstructive osteotomies such as shelf operation, rotational acetabular osteotomy (RAO), and Chiari osteotomy have also shown to provide long-term satisfactory outcomes.10 Despite the favorable outcomes associated with corrective osteotomies, some patients will still develop degenerative changes of the hip and may eventually require total hip arthroplasty (THA).11
Both dysplastic patients that did undergo a corrective osteotomy and those who did not present a distinct set of technical challenges on a subsequent THA.12,13 Therefore, it is essential to weight the outcomes following THA in these two patients populations, particularly given the strong association between dysplasia and osteoarthritis of the hip.14
Thus, the aims of this systematic review were to (1) to investigate and compare the radiographic and intraoperative findings of patients undergoing total hip arthroplasty (THA) following a corrective pelvic osteotomy (PO) due to dysplasia, to a control group of patients who underwent THA but not PO and (2) to evaluate the outcomes, including patient reported outcomes and complications for secondary THA after PO. The study hypothesized that based on the technical challenges associated with a previous open surgery (i.e. PO), the study group may present with inferior outcomes compared to its control cohort.
2 Methods
2.1 Study Identification and search strategy
In February 2020, the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were used to identify relevant articles in the PubMed, Embase, and Cochrane databases. The following key terms used were “osteotomy”, “arthroplasty”, “replacement”, “hip”, “outcome assessment”, “treatment outcome”, and “patient reported outcome measures”.15
Two orthopaedic surgeons (S.A. and J.S.) performed the search and independently reviewed the titles and abstracts to determine relevant articles to proceed onto full-text review. Differences in opinion were resolved by a third, senior orthopaedic surgeon (B.G.D.) to confirm that the studies met the inclusion and exclusion criteria (Table 1). Studies were included only if all reviewers came to a consensus that they met the eligibility criteria.
| Inclusion Criteria | Exclusion Criteria |
| English languageCommented on pre-secondary procedure radiographic factors, or indications for failure | Review articlesTechnique articlesOpinion articlesCadaveric articlesCase seriesOverlapping patient populationsFewer than 10 patientsConcomitant femoral osteotomy |
2.2 Quality assessment
Three reviewers (S.A., J.S., and B.G.D.), using the Methodological Index for Non-Randomized Studies (MINORS) criteria, independently evaluated all selected articles for methodologic quality. This grading scheme has traditionally been used to grade clinical outcome studies.16 If unmentioned, the level of evidence of a study was determined using Spindler et al.‘s criteria.17 The grading scheme includes the following categories: a clearly stated aim; inclusion of consecutive patients; prospective collection data; end points appropriate to the aim of the study; unbiased assessment of the study end point; follow-up period appropriate for the aim of the study; loss to follow-up <5%; prospective calculation of study size; adequate control group; contemporary groups; baseline equivalence of groups; and adequate statistical analyses.
2.3 Data extraction
Microsoft Excel (Microsoft Office 2018, Microsoft, Redmond, WA) was used to organize the data from all included studies. Reviewers extracted the title, author, date of publication, number of hips, demographics, follow-up time, time interval between osteotomy and conversion to total hip arthroplasty, degree of dysplasia (Crowe classification), type of osteotomy, radiographic readings, intraoperative findings, complications, reoperations, and patient-reported outcome scores from each study.
2.4 Data collection
Study groups consisted of patients who were (1) indicated for a total hip arthroplasty after previous PO and (2) a control group (compound of nondysplastic and dysplastic patients), which was selected by including patients within the control cohorts of the studies who underwent a THA but did not undergo a previous PO. Patients reported outcomes (PROs) were summarized across the study sub-groups.
To estimate the effect size of the THA procedure, the standardized mean difference (SMD) was calculated for the Harris Hip Score (HHS) and the Merle d’Aubigne and Postel (MDP) rating system scores across the included studies using the method previously described by Griffin et al.18 This method requires average preoperative and postoperative scores in addition to the standard deviation of the mean preoperative score. In cases where the standard deviation was unavailable, it was estimated using the range.19,20 An SMD score of 0.2–0.49 was considered weak, a score of 0.5–0.79 was moderate, and a score ≥0.8 was considered large.21
3 Results
3.1 Study Identification
After screening 884 articles for eligibility (Fig. 1), 11 comparative studies were included within this systematic review.13,22–30

3.2 Quality assessment
All the studies reviewed were level III. Evaluation of the 11 non-randomized studies using the MINORS criteria, yielded a mean quality assessment score of 20.7 out of 24 (range: 18 to 23) for all comparative studies.
3.3 Study characteristics
In the reviewed articles, we identified seven different types of osteotomies: Chiari osteotomy (CO)24,26,27,30, eccentric rotational acetabular osteotomy (ERAO),22 Bernese PO,23 rotational acetabular osteotomy (RAO)22,24,25,28,29 Salter PO,31 shelf acetabuloplasty (SA),24 and triple innominate osteotomy (TIO).13 All studies reported on at least one group that underwent PO and THA and compared findings to a control group who only underwent conversion to THA.
Among the reviewed studies, there were a total of 783 hips. Overall, 363 hips underwent PO followed by a conversion to THA. The remaining 420 hips consisted of the control groups who were primary THA in dysplastic patients. Age, body mass index, and follow-up time ranged from 13 to 72 years, 17.3–32 kg/m2, and 1–18.5 years, respectively, for the PO prior to THA cohort. Interval between PAO and THA ranged from 1 to 23 years. The most common osteotomy type performed was RAO (127), followed by CO (96), Salter (43), Bernese (36), ERAO (36), SA (15), and TIO (13). Demographic data is contained in Table 2.
| Patient Demographics | |||||||||
| Study | Level of Evidence | MINORS Score | No. of Hips (Sex) | Age at THA, y, Mean ± SD (Range) | BMI, kg/m2 ± SD (Range) | Follow-up, years, Mean ± SD (Range/% Follow-up) | Interval between PO and THA (Range) | Type of Osteotomy | Degree of Dysplasia (Crowe Classification, Grade, %) |
| Osawa et al., 201621 | III | 19 | O: 52 (2 M (2 hips), 46 F (50 hips))Control: 104 (2 M, 94 F) | O: 56.5 ± 6.4 (44–74)Control: 57.0 ± 6.3 | O: 23.9 ± 4.0Control: 23.3 ± 3.6 | O: 5.4 ± 3.2 (1–14) yearsControl: 5.3 ± 3.1 years | 11.4 (1–23) years | Osteotomy: 36 cases of ERAO (eccentric rotational acetabular osteotomy) and 16 cases of RAO (rotational acetabular osteotomy) | Osteotomy: Grade I/II |
| Amanatullah et al., 201522 | III | 21 | B: 23 (6 M, 17 F)DDH: 23 (6 M, 17 F) | B: 38 ± 11DDH: 38 ± 10 | B: 29 ± 6DDH: 28 ± 7 | B: 10 ± 4 yearsDDH: 6 ± 4 years | 5 ± 3 (1–10) years | Bernese periacetabular osteotomy | B: all IDDH: I (22); II (2) |
| Tamaki et al., 201623 | III | 18 | CO: 13 (1 M, 12 F)RAO: 21 (22 F)SA: 15 (3 M, 13 F) | CO: 57.5 ± 7.6 (44–70)RAO: 56.8 ± 11.6 (34–73)SA: 54.6 ± 7.2 (13–43) | CO: 22.6 ± 10 (19–30)RAO: 23.2 ± 3.1 (20–31)SA: 23.8 ± 4.0 (16–31) | CO: 3.5 ± 1.6 (2–7) yearsRAO: 3.8 ± 1.9 (2–7) yearsSA: 4.0 ± 1.4 (2–6) years | CO: 22.4 ± 10.5 (4–39) monthsRAO: 20.7 ± 7.6 (8–35) monthsSA: 28.1 ± 10.5 (13–43) months | Chiari pelvic osteotomy, rotational acetabular osteotomy, shelf acetabuloplasty | NR |
| Ito et al., 201524 | III | 23 | RAO: 44 (2 M, 40 F)Control (THA): 58 (2 M, 56 F) | RAO: 55.6 ± 7.8 (36–72)Control: 56.2 ± 5.1 (46–67) | RAO: 22.8 ± 3.4 (17.3–32.0)Control: 22.3 ± 2.7 (17.5–27.6) | RAO: 55.8 ± 36.2 (24–107)Control: 62.9 ± 28.4 (24–95) months | 21 ± 7.3 (7–37) months | Rotational acetabular osteotomy | RAO: I (29), II (10), III (3), IV (2)Control: I (39), II (14), III (4), IV (1) |
| Slavkovic et al., 201334 | III | 22 | CO: 46 (1 M, 45 F; 7 bilateral)Control: 47 (47 F; 11 bilateral) | CO: 54.6 ± 8.5Control: 55.7 ± 7.3 | NR | 66.6 ± 38.3 (36–222) months | 194.2 ± 75.8 months (48–423 months) | Chiari pelvic osteotomy | NR |
| Peters et al., 200113 | III | 21 | TIO: 13 (9F, 2 M)Control: 13 (9F, 2 M) | TIO: 37 (16–50)Control: 41 (17–54) | TIO weight: 13 kgControl weight: 13 kg | TIO: 36 moControl: 28 mo | *6 years (2–7) | Triple Innominate Osteotomy | NR |
| Hashemi-Nejad et al., 200225 | III | 20 | CO: 28 (2 M, 26 F)Control: 50 (4 M, 42F) | CO: 45 (38–64)Control: 39 (25–51) | NR | 60 (25–199) mo | 61 months (24–197 months) | Chiari pelvic osteotomy | CO: I (20), II (7), III (1), IV (0)Control: I (36), II (8), III (4), IV (2) |
| Minoda et al., 200626 | III | 21 | CO: 10 (10F)Control: 20 (20F) | CO: 55.4 ± 7.2Control: 56.3 ± 4.6 | CO: 22.3 ± 2.0Control: 23.0 ± 3.2 | CO: 2.7 ± 1.1 (2–5) moControl: 3.1 ± 1.1 (2–5) mo | 15 years (5–20 years) | Chiari pelvic osteotomy | CO: I (0), II (4), III (6), IV (0)Control: I (0), II (8), III (12), IV (0) |
| Yuasa et al., 201527 | III | 21 | RAO: 24 (3 M, 18F)Control: 24 (4 M, 19F) | RAO: 57.1 ± 9.8Control: 59.8 ± 8.2 | RAO: 23.4 ± 1.85Control: 23.0 ± 2.94 | RAO: 85 (15–195) moControl: 86 (16–192) mo | 135 months (13–197) | Rotational acetabular osteotomy | NR |
| Fukui et al., 201528 | III | 22 | RAO: 22 (2 M, 18F)Control: 30 (2 M, 26F) | RAO: 53.6 (46–62)Control: 55.8 (46–71) | RAO: 23.1Control: 23.0 | RAO: 8.2 years (7–11 years)Control: 8.7 years (7–11) | 12.7 years (3.5–19.4) | Rotational acetabular osteotomy | RAO: I (18), II (4)Control: I (27), II (3) |
| Tokunaga et al., 201130 | III | 22 | PO group (2 M, 43F):Salter: 40Chiari: 9Salter and Chiari: 3Control: 51 (2 M, 40 F) | PO: 41 (25–58)Control: 47 (27–66) | NR | PO: 7.3 years (3–15 years)Control: 8.5 years (3–17 years) | Salter: 22.6 years (4–40)Chiari: 19.3 years (1–40)Salter and Chiari: 12.7 years (3–18) | Salter osteotomyChiari pelvic osteotomy | PO: I (48), II (4)Control: I (46), II (5)P-value: 0.0006 |
3.4 Clinical assessment
Five of the eleven studies reported clinical assessment pre-and-postoperatively. Fukui et al.16 reported zero patients with a positive Trendelenburg sign at latest follow-up. Osawa et al.22 reported no significant difference in pre-and-postoperative range of motion however noted that there were lower flexion, abduction, external rotation, and internal rotation in the control group compared to the group undergoing PO before THA. Ito et al.25 found that the preoperative range of hip motion was poorer in the THA after RAO group. Tamaki et al.24 assessed clinical pain, range of motion and gait using the Japanese Orthopaedic Association (JOA) hip score before and after surgery, recording a significant improvement in final follow-up pain, range of motion, and gait. Minoda et al.27 used the Merle d’Aubigne and Postel rating system to evaluate pre-operative clinical pain, range of motion and walking ability between their study group (CO) and control group, citing no significant differences between the two groups preoperatively and postoperatively.
3.5 Radiographic measurements/findings
Eight of the eleven studies provided at least one radiographic measurement assessing their cohort's hip joint morphology.8,13,22,23,25–27,29,30 Seven studies reported on acetabular inclination before THA.13,22,23,25–27,29,30 Of these seven studies, one reported significantly decreased inclination in the osteotomy group when compared to control. The remaining studies report similar inclination values between osteotomy and control groups. Five of the eleven studies provided data on cup anteversion.22,23,26,27,29 Of the five studies, three recorded reduced cup anteversion in the osteotomy group compared to control.22,23,29 Two studies showed similar cup anteversion between osteotomy and control groups. One study described cup placement within the safe zones, showing a significant difference in cup safe zone placement between osteotomy (36, 69%) and control (87, 84%) groups (P = 0.038).22 Three of the eleven studies recorded both the horizontal and vertical distance of the hip joint center.22,25,29 One study demonstrated a significantly greater vertical distance to hip joint center in the osteotomy group than in the control whereas all three studies demonstrated a significantly greater horizontal distance to hip joint center in the osteotomy group than in the control. Radiographic measurements/findings are summarized in Table 3.
| Radiographic Measurements/Findings | ||||||
| Study | Socket Inclination/Abduction Angle | Socket Anteversion | Safe Zone (hips) | Hip Joint center (vertical distance, mm) | Hip Joint center (horizontal distance, mm) | Socket center edge angle/LCEA/ACEA before THA |
| Osawa et al., 201621 | O: 45.8 ± 6.2Control: 45.9 ± 5.7P = 0.863 | O: 13.6 ± 6.8Control: 16.1 ± 6.7P < 0.01 | O: 36 (69%)Control: 87 (84%)P = 0.038 | O: 23.4 ± 6.3Control: 22.5 ± 6.4P = 0.143 | O: 33.2 ± 5.8Control: 30.7 ± 5.2P < 0.01 | O: 37.3 ± 10.4Control: 26.4 ± 12.2P < 0.01 |
| Amanatullah et al., 201522 | B: 44.7 ± 6.6DDH: 45.6 ± 7.2P = 0.677 | B: 26.3 ± 9.8DDH: 36.0 ± 8.2P = 0.002 | NR | NR | NR | ACEA:B: 28 ± 23DDH: NRLCEA:B: 20 ± 15DDH: NR |
| Tamaki et al., 201623 | NR | NR | NR | NR | NR | NR |
| Ito et al., 201524 | RAO: 40.7 ± 5.2 (30–52)Control: 43.5 ± 8.2 (22–66)P = 0.02 | NR | NR | RAO: 25.7 ± 6.5 (11–40)Control: 23.7 ± 5.7 (13–41)P = 0.09 | RAO: 31.2 ± 5.3 (21–42)Control: 28.1 ± 3.8 (19–37)P = 0.002 | NR |
| Slavkovic et al., 201334 | CO: 41.8 ± 9.8Control: 45.4 ± 8.6 | NR | NR | NR | NR | NR |
| Peters et al., 200113 | TIO: 39 ± 18Control: 35 ± 15 | NR | NR | NR | NR | NR |
| Hashemi-Nejad et al., 200225 | CO: 45 (31–60)Control: 42 (22–62) | CO: 10 (1–24)Control: 12 (-8-24) | NR | NR | NR | NR |
| Minoda et al., 200626 | NR | CO: 17.3 ± 5.0Control: 16.7 ± 5.4P = 0.750 | NR | NR | NR | NR |
| Yuasa et al., 201527 | NR | NR | NR | NR | NR | NR |
| Fukui et al., 201528 | RAO: 41.1 ± 5.4Control: 39.4 ± 4.0P = 0.3263 | RAO: 16.9 ± 6.1Control: 26.1 ± 5.6P < 0.0001 | NR | RAO: 28.4 ± 7.3Control: 23.5 ± 5.4P = 0.0206 | RAO: 38.1 ± 4.4Control: 31.4 ± 4.6P < 0.0001 | LCEA:RAO: 27 (3–42)Control: 16 (10–23)P < 0.0001 |
| Tokunaga et al., 201130 | NR | NR | NR | NR | NR | NR |
3.6 Intraoperative findings
Nine of the eleven studies assessed recorded mean operative time and blood loss in both the control and study groups.13,22–29 Operative time ranged from 57.7 to 177 min in the study groups and 50.9–174 min in the control groups. Three studies reported a significantly increased operation time for their study group compared to their control, whereas one study reported significantly increased operation time in their control group compared to their study group. Mean blood loss ranged from 136 to 1598 mL for the study groups and 50.9–1192 mL for the control groups. Two studies reported a significantly increased exsanguination for their study group compared to their control, whereas one study reported significantly increased exsanguination in their control group compared to their study group.
Other intraoperative findings include the need of anterior rim trimming due to bony impingement after THA. Ito et al.25 required anterior rim trimming in 40/44 study group cases (90.9%) whereas it was required in 31/58 control group cases (53.4%). Amanatullah et al.23 also noted that anterior rim trimming was needed due to retroversion of the acetabulum. Moreover, Tamaki et al.24 required bulk bone augmentation significantly more in the Chiari and RAO groups than in the control group (p = 0.02 and p < 0.001, respectively). The intraoperative findings are summarized in Table 4.
| Intraoperative Findings | ||
| Study | Operative time (min) | Blood loss (range) |
| Osawa et al., 201621 | Osteotomy: 86.1 ± 26.1Control: 76.2 ± 24.5P-0.025 | Osteotomy: 358 g ± 217 gControl: 345 g ± 214 gP = 0.745 |
| Amanatullah et al., 201522 | PAO: 151 ± 65DDH: 174 ± 40P = 0.155 | PAO: 630 g ± 383 gDDH: 741 g ± 655 gP = 0.576 |
| Tamaki et al., 201623 | CO: 57.7 ± 11.7 (38–74)RAO: 72.6 ± 24.8 (33–138)SA: 58.3 ± 20.6 (32–116)Control: 50.9 ± 18.5 (21–198)P>0.05* | CO: 406 g ± 277 g (80–850 g)RAO: 475 g ± 412 g (25–1770 g)SA: 406 g ± 146 g (80–600 g)Control: 50.9 g ± 18.5 g (21–198 g)P>0.05* |
| Ito et al., 201524 | RAO: 177 ± 41 (115–227)Control: 161 ± 36 (91–206)P = 0.03 | RAO: 567 g ± 232 (140–1445 g)Control: 524 g ± 254 g (50–1710 g)P = 0.15 |
| Slavkovic et al., 201334 | NR | NR |
| Peters et al., 200113 | TIO: 130 (100–167)Control: 118 (78–170) | TIO: 721 mL (300–1500 mL)Control: 448 mL (300–700 mL) |
| Hashemi-Nejad et al., 200225 | CO: 97 (70–126)Control: 111 (75–145)P < 0.05 | CO: 662 mL (285–1000)Control: 1020 mL (200–2100)P < 0.05 |
| Minoda et al., 200626 | CO: 127 ± 20Control: 102 ± 23P = 0.007 | CO: 1598 mL±317 mLControl: 1192 mL±304 mLP = 0.002 |
| Yuasa et al., 201527 | RAO: 151.8 ± 36.9Control: 111.4 ± 20.4 | RAO: 530.9 g ± 80.1 gControl: 422.1 g ± 143.5 g |
| Fukui et al., 201528 | RAO: 89.5Control: 96.6P = 0.1431 | RAO: 136.0 mLControl: 131.3 mLP = 0.5318 |
| Tokunaga et al., 201130 | NR | NR |
3.7 General PROs and clinical assessment
The most commonly used PROs were the HHS and MDP. Outcome measures for the osteotomy before THA and control groups are displayed in Table 5.
| Patient-Reported Outcome Scores | ||||
| Study | Preoperative score | Postoperative score | P-Value | Satisfaction |
| Osawa et al., 201621 | NR | HHS:Osteotomy: 87.4Control: 92.6P<.01 | NR | NR |
| Amanatullah et al., 201522 | HHS:THA after PAO: 67 ± 17THA for DDH: 51 ± 15P = 0.004 | HHS:THA after PAO: 93 ± 7THA for DDH: 95 ± 10 | <.001<.001 | 10 (5–10) |
| Tamaki et al., 201623 | JOA:CO: 48.2RAO: 45.7SA:52.8P = 0.214 | JOA:CO: 89.3RAO: 90.6SA: 92.7P = 0.607 | NR | NR |
| Ito et al., 201524 | MDP:THA after RAO: 8.3 ± 1.7 (5-12Control: 8.4 ± 2.1 (4–13)P = 0.74 | MDP:THA after RAO: 15.2 ± 1.7 (11–18)Control: 15.7 ± 1.8 (11–18)P = 0.12 | <0.05 | NR |
| Slavkovic et al., 201334 | HHS:CO:46.5 ± 12.0Control: 57.2 ± 11.1 | HHS:CO: 84.0 ± 13.4Control: 82.1 ± 8.3P < 0.015 | <0.001<0.001 | NR |
| Peters et al., 200113 | HHS:TIO: 40Control: 28P = 0.04 | HHS:TIO: 76Control: 88P < 0.05 | 0.04 | 90.7±12 |
| Hashemi-Nejad et al., 200225 | HHS:CO:43 (23–75)Control: 38 (20–65) | HHS:CO: 79 (50–99)Control: 81 (21–100) | NR | CO: 88 (44–100)Control: 85 (20–100) |
| Minoda et al., 200626 | MDP:CO: 6.6 ± 1.7Control: 7.6 ± 1.5P = 0.915 | MDP:CO: 16.3 ± 0.7Control: 16.1 ± 0.9P = 0.545 | NR | 90.7±12 |
| Yuasa et al., 201527 | HHS:RAO: 48.3 ± 8.76Control: 48.5.5 ± 4.82P = 0.922 | HHS:RAO: 82.9 ± 9.01Control: 86.5 ± 4.75P = 0.111 | NR | NR |
| Fukui et al., 201528 | HHS:RAO: 48.6Control: 48.8 | HHS:RAO: 93.2Control: 94.3 | NR | NR |
| Tokunaga et al., 201130 | HHS:PO: 51Control: 49P = 0.627 | HHS:PO:85Control: 87P = 0.438 | NR | NR |
Comparing the preoperative scores for the control and PO before THA study groups, one study reported significantly higher PROs for the control group,30 one study reported significantly higher PROs for the study group,13 four studies did not show any significant difference in PROs between their cohort and study groups24,27,28 and five studies did not report a p-value comparing the control and study groups22,25,26,29,.30 For postoperative scores, two studies reported significantly higher PROs for the control group than the study group13,22, one study reported significantly higher PROs for the study group than the control group,30 four studies did not show any significant difference in PROs between their cohort and study groups25,27,28 and four studies did not report a p-value comparing the control and study group's postoperative scores.23,24,26,29
Four of the ten studies reported patient satisfaction after THA, which was high (85–90.7 out of 100 in three studies13,26,27 median of 10 out of 10 in one study23). No significant differences were found between both groups.
3.8 Standardized mean difference and heterogeneity
A summary of the SMD values for all studies reporting HHS can be found in Fig. 2. Of the eight articles with a recorded HHS, four provided sufficient information for effect sizes to be estimated based on HHS.23,26,28,30 All articles demonstrated a large effect size of ≥0.8. Yuasa et al.‘s28 control group had a substantially large effect size with SMD of 7.9, whereas their RAO group had SMD of 3.9, indicating a significantly larger effect of THA on the control group. All articles demonstrated a large effect size of ≥0.8.

3.9 Complications and reoperations
Complications and reoperations are summarized in Table 6. The overall complication rates were 8.8% (31/353) and 4.5% (17/375) for the study groups and the control groups, respectively. The most common complication throughout the study groups was dislocations (10/353, 2.8%), followed by hardware breakages (5/353, 1.4%) and intraoperative femoral fractures (4/353, 1.1%). The rate of component loosening, and acetabular cup migration was low, however, when it presented as in Hashemi-Nejad et al.,26 either abduction angle exceeded 50° or coverage of the cup was suboptimal.
| Complications and Reoperations | ||
| Study | Complications | Reoperations |
| Osawa et al., 201621 | Osteotomy: 1 dislocationControl: 1 dislocation | None |
| Amanatullah et al., 201522 | B: 2 dislocations, 1 superficial wound-healing problemDDH: noneP = 0.489 | B: 2 revisions for dislocationsDDH: 1 revision for aseptic loosening, 1 for problems related to metal-on-metal articulation |
| Tamaki et al., 201623 | CO: 1 dislocationRAO: 2 acetabular cup migrationsSA: noneControl: none | RAO: 2 acetabular augmentation with bulk bone in primary THA |
| Ito et al., 201524 | RAO: noneControl: 1 infection, 2 venous thromboembolisms | RAO: 0Control: 1 |
| Slavkovic et al., 201334 | CO: 5 hardware breakage, 1 non-union, 1 femoral head avascular necrosis, 1 wound healing delay, 1 joint contracture | NR |
| Peters et al., 200113 | TIO: 3 intraoperative femoral fractures, 2 dislocations, 1 perioperative infectionControl: 1 intraoperative femoral fracture, 1 dislocation | TIO: 1 revision for dislocationControl: 1 revision |
| Hashemi-Nejad et al., 200225 | CO: 1 femoral nerve palsyControl: 3 femoral fractures, 2 deep venous thrombosis | CO: 1 revisionControl: 6 revisions |
| Minoda et al., 200626 | NR | NR |
| Yuasa et al., 201527 | RAO: 1 infectionControl: none | RAO: 4 revisionsControl: 1 revisionP = 0.165 |
| Fukui et al., 201528 | RAO: noneControl: none | RAO: noneControl: none |
| Tokunaga et al., 201130 | PO: 7 total (1 fracture, 4 dislocations, 2 infections, 1 nerve damage)Control: 6 total (3 fractures, 2 dislocations, 1 deep vein thrombosis)P = 0.795 | PO: 15 revisions (12 for loosening, 2 for dislocations, 1 for infection)Control: 10 revisions (9 for loosening, 1 for dislocation)P = 0.581 |
The overall reoperation rate was 7.7% (25/326 hips) for the THA after a prior PAO study cohort hips and 5.5% (21/379 hips) for all control group hips. The most common indication for revision was dislocations and aseptic loosening.
4 Discussion
The purpose of this systematic review was to investigate the radiographic and intraoperative findings as well as the outcomes in patients undergoing hip arthroplasty who previously underwent PO for acetabular dysplasia. Common postoperative radiographic findings were higher version of the acetabular component and larger horizontal offset for the PO group. Intraoperatively, patients after previous PO often required posterior wall bone graft and anterior wall trimming. Blood loss was mostly either the same or higher for the PO groups compared to the non-PO group. Both groups demonstrated a significant improvement in PROs at their last follow-up relative to their preoperative scores. The PO group reported either equivalent or inferior postoperative outcomes compared with the non-PO group. No significant difference was found related to complications and reoperations; however, a unique subset of postoperative instability was noted due to resorption of the structural bone graft for the PO group.
Of the 11 reviewed studies, eight and nine studies evaluated radiographic and intraoperative findings, respectively.13,22–30 Parvizi et al. aimed in their study to investigate the technical aspects of THA in patients with prior PAO and outline the associated challenges.11 Overall, 41 patients who had THA following PAO were enrolled in their study. Mean follow-up was 6.9 years. The authors noted that one of the technical challenges encountered in patients undergoing THA after PO was due to retroverted position of the acetabulum. Despite the association between retroversion of the acetabulum and the cup, the authors did not advocate the routine use of a structural bone graft to reinforce the posterior wall. However, the senior author had routinely utilized a Ganz cage regardless of bone quality or anatomy, which might had obviated the need for an additional bone graft. Similarly, out of the five studies that reported on cup version, three demonstrated decreased version of the acetabular component for the PO group relative to the non-PO group.22,23,29 In contrast, the inclination of the cup was similar between the groups in six of the seven studies that reported on this measurement.13,22,23,26,29,30 Two studies explicitly reported on the use of structural bone graft due to a deficiency in the posterior wall amongst the PO group.23,26, In two studies, an additional trimming of the anterior wall was required due to a retroverted acetabulum.23,25 Moreover, most studies that reported on blood loss during the arthroplasty procedures noted either similar or increased blood loss for the PO group, attributing this finding to the difficulty associated with the previous PO procedure and with difficult exposure and dislocation of the femoral head associated with the retroverted acetabulum.
All 11 studies enrolled in this systematic review reported on postoperative PROs. Of these, ten reported on preoperative PROs.13,23–31 Hartig-Andreasen et al. aimed in their study to investigate the association between cup positioning and the potential complications in patients undergoing THA following a prior PAO.32 Overall, 34 patients (38 hips) were included in their study. Follow-up ranged between 4 and 10 years after the arthroplasty procedure. Mean cup anteversion and abduction were 22° and 45°, respectively. Regarding outliers in cup position, anteversion for 13 of the cups was >25°, inclination for nine cups was >50°, and <30° for one cup. The authors attributed these outliers to a persistent dysplasia. Despite the lack of consistency in accurate cup positioning, patients reported good median outcome scores for HHS, Oxford hip score and WOMAC.33 Nevertheless, they acknowledged the challenge in accurate cup positioning in patients following a prior PAO. In this systematic review, eight studies reported similar preoperative functional scores and nine reported similar postoperative functional scores for the PO and the non-PO groups. Two studies reported better postoperative scores for the non-PO group.13,22 Similar to Hartig-Andreasen et al., one of the reviewed studies also demonstrated inconsistency in placing the acetabular components within the “safe-zone” for the PO group, however the accuracy was better for the non-PO group (69% vs 84%, respectively).22 Moreover, since they had a control group, showing not only better accuracy for cup positioning, but also more favorable outcomes, the authors associated the poorer outcomes with the challenging cup positioning in patients following PAO. These outcomes emphasizing the need for meticulous attention for cup positioning in THA, particularly following PO.
All eleven studies listed the THA perioperative complications and reoperations.
Sadoghi et al. aimed to perform a complication-based analysis in case of revision arthroplasty procedures, utilizing worldwide arthroplasty registers.34 For total hip arthroplasty, the authors used register data from Sweden, Norway, Finland, Denmark, Australia, and New Zealand including 485,790 primary and 77,036 (15%) cases of revised THAs performed between the years 1979 and 2009. Causes of revision in descending order were aseptic loosening (55.2%), instability (11.8%), septic loosening (7.5%), periprosthetic fractures (6%), wear (4.2%), pain without other cause (3.7%), implant breakage (2.5%), and technical error (3.8%). In this study the complications distribution was different compared to the data collected for the register. The overall complications documented in the reviewed studies in descending order were dislocations (6/311, 1.9%), hardware breakages (5/311, 1.6%), and intraoperative femoral fractures (3/311, 1.0%). Peters et al. reported three femoral fractures in their study group which were treated with cerclage, causing increased blood loss during the procedure.13 Hashemi-Nejad et al. attributed cup abduction angle of >50° or suboptimal coverage of the cup to aseptic loosening.26 Although an overall qualitative or quantitative comparison of the complication between the two cohorts was not feasible, the unique distribution of these complications reflects the challenges imposed by the distinct anatomy presented by both patients cohorts.
These findings further stress the need for a careful pre- and intraoperative planning, assessment of the surgical approach, and prostheses positioning.
4.1 Limitations
This study has some limitations. First, a quantitative analysis (i.e. metanalysis) between the studies was not possible due to the lack of randomized control studies. However, the quality of this systematic review was maintained due to selecting only case control studies. This selection allowed the comparison within studies, required for an adequate qualitative analysis (i.e. systematic review).
5 Conclusion
Pelvic osteotomy secondary to dysplasia may entail some challenges on a subsequent THA, illustrated by higher intraoperative blood loss, lower consistency in cup positioning and possibly compromised patients reported outcomes, compared to their dysplastic counterpart who were not treated with PO. The distinct anatomy associated with both cohorts may result in a different distribution of perioperative complications.
Ethical
This study was performed in accordance with the ethical standards in the 1964 Declaration of Helsinki. This study was carried out in accordance with relevant regulations of the US Health Insurance Portability and Accountability Act (HIPAA). Details that might disclose the identity of the subjects under study have been omitted. This study was approved by the IRB. (IRB ID: 5276).
References
- The etiology of osteoarthritis of the hip: an integrated mechanical concept. Clin Orthop. 2008;466(2):264-272.
- [Google Scholar]
- Periacetabular osteotomy: a systematic literature review. Clin Orthop. 2009;467(8):2041-2052.
- [Google Scholar]
- Innominate osteotomy in the treatment of congenital dislocation and subluxation of the hip. J Bone Joint Surg Br. 1961;43(3):518-539.
- [Google Scholar]
- A modified technique of the triple pelvic osteotomy: early results. J Pediatr Orthop. 1981;1(3):241-249.
- [Google Scholar]
- Rotational acetabular osteotomy for the dysplastic hip. J Bone Joint Surg Am. 1984;66(3):430-436.
- [Google Scholar]
- A new periacetabular osteotomy for the treatment of hip dysplasias technique and preliminary results. Clin Orthop Relat Res. 1988;232:26-36.
- [Google Scholar]
- Osteotomies about the hip for the prevention and treatment of osteoarthrosis. JBJS. 1995;77(4):626-647.
- [Google Scholar]
- Natural history of the dysplastic hip following modern periacetabular osteotomy. J Bone Joint Surg Am. 2019;101(10):932-938.
- [Google Scholar]
- Open treatment of dysplasia—other than PAO: does it have to be a PAO? J Hip Preserv Surg. 2017;4(2):131-144.
- [Google Scholar]
- Previous Bernese periacetabular osteotomy does not compromise the results of total hip arthroplasty. Clin Orthop. 2004;423:118-122.
- [Google Scholar]
- Challenges in total hip arthroplasty in the setting of developmental dysplasia of the hip. J Arthroplasty. 2017;32(9):S38-S44.
- [Google Scholar]
- Total hip arthroplasty in young adults after failed triple innominate osteotomy. J Arthroplasty. 2001;16(2):188-195.
- [Google Scholar]
- The John Charnley award: redefining the natural history of osteoarthritis in patients with hip dysplasia and impingement. Clin Orthop. 2017;475(2):336-350.
- [Google Scholar]
- Preferred reporting Items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7)
- [Google Scholar]
- Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712-716.
- [Google Scholar]
- Reading and reviewing the orthopaedic literature: a systematic, evidence-based medicine approach. J Am Acad Orthop Surg. 2005;13(4):220-229.
- [Google Scholar]
- Outcomes of hip arthroscopy in the older adult: a systematic review of the literature. Am J Sports Med. 2016;18
- [Google Scholar]
- Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13.
- [Google Scholar]
- Significantly poor outcomes of total hip arthroplasty after failed periacetabular osteotomy. J Arthroplasty. 2016;31(9):1904-1909.
- [Google Scholar]
- Similar clinical outcomes for THAs with and without prior periacetabular osteotomy. Clin Orthop. 2015;473(2):685-691.
- [Google Scholar]
- Total hip arthroplasty after previous acetabular osteotomy: comparison of three types of acetabular osteotomy. J Arthroplasty. 2016;31(1):172-175.
- [Google Scholar]
- Total hip arthroplasty after rotational acetabular osteotomy. J Arthroplasty. 2015;30(3):403-406.
- [Google Scholar]
- Does Chiari osteotomy compromise subsequent total hip arthroplasty? J Arthroplasty. 2002;17(6):731-739.
- [Google Scholar]
- Total hip arthroplasty of dysplastic hip after previous Chiari pelvic osteotomy. Arch Orthop Trauma Surg. 2006;126(6):394-400.
- [Google Scholar]
- Total hip arthroplasty after previous rotational acetabular osteotomy. Eur J Orthop Surg Traumatol. 2015;25(6):1057-1060.
- [Google Scholar]
- Does rotational acetabular osteotomy affect subsequent total hip arthroplasty? Arch Orthop Trauma Surg. 2015;135(3):407-415.
- [Google Scholar]
- Acetabular Component Position of the Noncemented Total Hip Endoprosthesis after Previous Chiari Pelvic Osteotomy. 2013:8.
- [Google Scholar]
- Effect of prior salter or chiari osteotomy on THA with developmental hip dysplasia. Clin Orthop. 2011;469(1):237-243.
- [Google Scholar]
- Is cup positioning challenged in hips previously treated with periacetabular osteotomy? J Arthroplasty. 2014;29(4):763-768.
- [Google Scholar]
- Dislocations after total hip-replacement arthroplasties. J Bone Joint Surg Am. 1978;60(2):217-220.
- [Google Scholar]
- Revision surgery after total joint arthroplasty: a complication-based analysis using worldwide arthroplasty registers. J Arthroplasty. 2013;28(8):1329-1332.
- [Google Scholar]

